|
34 |
Preparing A framework For Artificial Intelligence And Machine Learning Validation: A 3-Step Approach
|
sureAssist |
2024-12-26 |
792 |
|
33 |
CGMP Requirements For Automated Facility Monitoring Systems
|
sureAssist |
2024-12-26 |
671 |
|
32 |
RTU vs concentrate disinfectants: efficiency as a factor in selection
|
sureAssist |
2024-12-26 |
681 |
|
31 |
EMA phases out extraordinary COVID-19 regulatory flexibilities
|
sureAssist |
2024-12-26 |
655 |
|
30 |
6 Ways To Achieve Manufacturing Audit And Inspection Readiness
|
sureAssist |
2024-12-26 |
695 |
|
29 |
FDA issues draft guidance on reporting manufacturing changes for gene therapies
|
sureAssist |
2024-12-26 |
695 |
|
28 |
Aseptic filling PUPSIT: What is it? Should I? Must I? How do I? Where do I?
|
sureAssist |
2024-12-26 |
1,338 |
|
27 |
FDA now also assesses Countries and Regions as a Risk Factor
|
sureAssist |
2024-12-26 |
707 |
|
26 |
Navigating Regulatory Guidelines For Effective Tech Transfer
|
sureAssist |
2024-12-26 |
671 |
|
25 |
Industry first experiments for decontaminating RTU vials with vaporised H2O2
|
sureAssist |
2024-12-26 |
767 |
